NEW YORK (GenomeWeb) – Invitae reported after the close of the market Monday a more than threefold year-over-year increase in second quarter revenues.

For the three months ended June 30, Invitae reported $5.6 million in revenues compared to $1.8 million in the year ago period, falling short of the consensus Wall Street estimate of $5.8 million.

Invitae grew its test volume by 170 percent year over year, billing more than 12,000 reports and accessioning more than 12,500 samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.

Sponsored by

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sponsored by

This webinar will discuss an approach for automating variant classification based on the American College of Medical Genetics and Genomics guidelines.

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.